Capital Change Notice – Share Options

Capital Change Notice




Section 1: Issuer information
Name of issuer Rua Bioscience Limited.
NZX ticker code RUA
Class of financial product

Options to subscribe for
Ordinary Shares in the Issuer
(Options).
ISIN (If unknown, check on NZX website) NZRUAE0004S1
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 2,100,000
Nominal value (if any) Nil
Issue price per security $0.00
Nature of the payment (for example, cash or other
consideration)
Zero cash – provision of
employment and personal
services to the Issuer.
Amount paid up (if not in full) N/A (as issued for no cash
consideration).
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of
Financial Products of the Class, excluding any Treasury Stock,
in existence)
1

1.33% (2dp) of the total
number of Ordinary Shares on
issue (undiluted).
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion
price and Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial Product) or the
Option (for example, the exercise price and exercise date)
The Options will vest and
convert into Ordinary Shares in
the Issuer in a ratio of 1:1, for
NIL cash consideration, on
3 June 2024 subject to
conditions set out in Option
Deeds for each Participant
dated May 2023.
Reason for issue/acquisition/redemption and specific authority
for issue/acquisition/redemption/ (the reason for change must
be identified here)
Consideration for services and
performance incentive for
employees (part of
remuneration package)
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding Treasury
Stock) and the total number of Financial Products of the Class
held as Treasury Stock after the issue/acquisition/redemption.
Total number of Options of this
class after the issue will be
4,550,000
In the case of an acquisition of shares, whether those shares
are to be held as treasury stock
N/A

1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Specific authority for the issue, acquisition, or redemption,
including a reference to the rule pursuant to which the issue,
acquisition, or redemption is made
Listing rule 4.6.1 and 4.11.1
Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
Options vest and convert into
Ordinary Shares on 3 June
2024 subject to conditions set
out in Option Deeds for each
Participant dated May 2023.
Participant to pay associated
tax liability.
Date of issue/acquisition/redemption
2
Grant date for the Options is
1 June 2023.
Date for issue of the Ordinary
Shares on conversion is 3 June
2024.
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this announcement Hamish White
Contact person for this announcement Paul Naske
Contact phone number 021445154
Contact email address Paul.naske@ruabio.com
Date of release through MAP

[01/06/2023]




2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).